<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0480">
 <label>96</label>
 <element-citation publication-type="journal" id="rf0425">
  <person-group person-group-type="author">
   <name>
    <surname>Hulseberg</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Fénéant</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Szymańska-de Wijs</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Kessler</surname>
    <given-names>N.P.</given-names>
   </name>
   <name>
    <surname>Nelson</surname>
    <given-names>E.A.</given-names>
   </name>
   <name>
    <surname>Shoemaker</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Schmaljohn</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Polyak</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>J.M.</given-names>
   </name>
  </person-group>
  <article-title>Arbidol and other low-molecular-weight drugs that inhibit lassa and ebola viruses</article-title>
  <source>J. Virol.</source>
  <volume>93</volume>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.1128/JVI.02185-18</pub-id>
  <comment>e02185-18, /jvi/93/8/JVI.02185-18.atom</comment>
 </element-citation>
</ref>
